home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Preparation for GMP Inspections by Regulatory Agencies

 
  February 08, 2017  
     
 
Compliance4All, Online Event
2017-04-05


Overview:  
This webinar will provide practical tips and advice for ensuring that all inspections are conducted in the most effective and efficient way possible, including ongoing readiness for inspections, rehearsals and preparation for successful facility inspections, and response to findings by regulatory agencies. 

Why should you Attend:
Good manufacturing practice (GMP) is the minimum standard that a manufacturer must meet in their production processes.
This webinar will review what to expect during the Agency inspection and how to successfully and efficiently streamline and manage the inspection, including adequate follow-up during and after the inspection. 

Areas Covered in the Session:
Types of Inspections (for cause, pre-approval, periodic ) > API & FDF
Notification Timing
Foreign Facilities
What to expect during Inspection
Do a company audit as the FDA would (fall dress rehearsal)
Make adjustments as needed/address issues/take needed actions
Managing the Inspection
Inspection on follow-up

Who Will Benefit:
Design Engineers
Manufacturing
Supply chain
Technical operations
Quality control
Quality assurance
Regulatory affairs

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com
 
 
Organized by: Compliance4All
Invited Speakers:
Speaker Profile: 
Peggy J. Berry , MBA, RAC, is the President & CEO at Synergy Consulting where she provides consulting services to companies in all aspects of drug development. She also provides group and one-on-one training in drug development, regulatory affairs and project management topics. Prior to founding Synergy Consulting in 2015, she was Vice President of Regulatory Affairs at Insmed (2/2015-5/2015) where she was responsible for the development and implementation of global regulatory strategies and the management and oversight of the regulatory affairs department.
 
Deadline for Abstracts: 2017-04-04
 
Registration:

Registration Link:

http://www.compliance4all.com/control/w_product/~product_id=501225LIVE?channel=mailer&camp=Webinar&AdGroup=hum-molgen_Apr_2017_SEO 

E-mail: support@compliance4All.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.